TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $90,400,000 | -0.3% | 5,518,932 | +2.5% | 0.01% | +12.5% |
| Q2 2021 | $90,651,000 | -8.7% | 5,386,303 | -0.9% | 0.01% | -20.0% |
| Q1 2021 | $99,278,000 | +1.7% | 5,436,898 | +1.4% | 0.01% | 0.0% |
| Q4 2020 | $97,600,000 | +1.6% | 5,362,644 | -0.4% | 0.01% | -9.1% |
| Q3 2020 | $96,043,000 | -2.5% | 5,383,566 | -2.0% | 0.01% | -8.3% |
| Q2 2020 | $98,531,000 | +16.6% | 5,495,336 | -1.3% | 0.01% | -7.7% |
| Q1 2020 | $84,514,000 | +4.2% | 5,567,466 | +35.5% | 0.01% | +18.2% |
| Q4 2019 | $81,078,000 | +13.4% | 4,109,398 | -1.1% | 0.01% | +10.0% |
| Q3 2019 | $71,490,000 | -3.3% | 4,156,367 | -0.5% | 0.01% | 0.0% |
| Q2 2019 | $73,913,000 | -39.1% | 4,175,898 | -29.9% | 0.01% | -44.4% |
| Q1 2019 | $121,336,000 | – | 5,956,597 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |